Form 8-K - Current report:
SEC Accession No. 0001213900-14-007263
Filing Date
2014-10-15
Accepted
2014-10-15 10:01:45
Documents
1
Period of Report
2014-10-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DANDRIT BIOTECH USA, INC. FORM 8-K f8k101414_dandrit.htm 8-K 18166
  Complete submission text file 0001213900-14-007263.txt   19394
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54478 | Film No.: 141156688
SIC: 2834 Pharmaceutical Preparations